SCHEMBL32905

SCHEMBL32905

NC1CCCCC1CC1CCCCC1N

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10237960 0.85 CA1 (0.45) THRBMEN1KMT2A
SCHEMBL18764347 0.84 THRB (0.43) THRBMEN1KMT2A
SCHEMBL10507608 0.83 THRB (0.38) THRBMEN1KMT2A
SCHEMBL17258239 0.83 THRB (0.38) THRBMEN1KMT2A
SCHEMBL20845358 0.82 CYP1A2 (0.37) THRBMEN1KMT2A
SCHEMBL32699 0.80 THRB (0.39) THRBMEN1KMT2A
SCHEMBL11210602 0.79
SCHEMBL9322177 0.79
SCHEMBL15338527 0.79
SCHEMBL1773831 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250376438-A1 METHOD FOR PRODUCING ISOCYANATES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES COVESTRO DEUTSCHLAND AG (DE) 2025-12-11 US claimed
EP-4543850-A1 METHOD FOR PRODUCING ISOCYANTES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES Covestro Deutschland AG (DE) 2025-04-30 EP claimed
EP-4543852-A1 PRODUCING SPECIAL ISOCYANATES VIA CO-PHOSGENATION Covestro Deutschland AG (DE) 2025-04-30 EP claimed
CN-119365443-A Process for producing isocyanates by phosgenation of mixtures of (aromatic) aliphatic diamines and cycloaliphatic diamines 科思创德国股份有限公司 2025-01-24 CN claimed
CN-119278196-A Production of specific isocyanates by co-phosgenation 科思创德国股份有限公司 2025-01-07 CN claimed
US-11992811-B2 Crosslinked hollow-fibre membranes and new process for manufacturing the same EVONIK OPERATIONS GMBH (DE) 2024-05-28 US claimed
WO-2023247525-A1 PRODUCING SPECIAL ISOCYANATES VIA CO-PHOSGENATION COVESTRO DEUTSCHLAND AG (DE) 2023-12-28 WO claimed
WO-2023247522-A1 METHOD FOR PRODUCING ISOCYANTES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES COVESTRO DEUTSCHLAND AG (DE) 2023-12-28 WO claimed
EP-4296260-A1 PREPARATION OF SPECIFIC ISOCYANATES BY CO-PHOSGENATING Covestro Deutschland AG (DE) 2023-12-27 EP claimed
CN-114805731-B Low-reactivity polyaspartic acid ester resin, preparation method, coating and preparation method 深圳飞扬骏研新材料股份有限公司 2023-10-20 CN claimed
EP-1593669-A1 Multi-step process for the continuous preparation of cycloaliphatic diisocyanates Degussa AG (DE) 2005-11-09 EP claimed
EP-1512681-A1 Multi-step process for the continuous preparation of cycloaliphatic diisocyanates Degussa AG (DE) 2005-03-09 EP claimed
EP-1512682-A1 Multi-step process for the continuous preparation of cycloaliphatic diisocyanates Degussa AG (DE) 2005-03-09 EP claimed
EP-1512680-A1 Multi-step process for the continuous preparation of cycloaliphatic diisocyanates Degussa AG (DE) 2005-03-09 EP claimed
EP-0002431-B2 TRANSPARENT POLYAMIDES AND THEIR USE FOR MAKING MOULDINGS BAYER AG (DE) 1985-03-20 EP claimed
EP-0012931-B1 COPOLYAMIDES BASED ON A MIXTURE OF CYCLOALIPHATIC AMINES AND MOULDED ARTICLES THEREOF BAYER AG (DE) 1983-09-14 EP claimed
EP-0002431-B1 TRANSPARENT POLYAMIDES AND THEIR USE FOR MAKING MOULDINGS BAYER AG (DE) 1981-03-25 EP claimed
US-4223127-A Polyamides from 2,4'-diaminodicyclohexyl methane BAYER AKTIENGESELLSCHAFT (DE) 1980-09-16 US claimed
EP-0012931-A2 Copolyamides based on a mixture of cycloaliphatic amines and moulded articles thereof BAYER AG (DE) 1980-07-09 EP claimed
EP-0002431-A1 Transparent polyamides and their use for making mouldings BAYER AG (DE) 1979-06-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250376438-A1 METHOD FOR PRODUCING ISOCYANATES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES APEH, CDIPT, DDT THRB 4545/4885MEN1 1980/4885KMT2A 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.